Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Boone

Showing results (101-110 of 169) with videos related to

Pageof 17
Sort By:
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1994
Chronic toxicity studies of the potential cancer preventive 2-(difluoromethyl)-dl-ornithineJ A Crowell, E I Goldenthal, G J Kelloff, et al.
Journal of Supramolecular Structure|January 1, 1978
Independence of normal phenotypic properties and cell surface receptor mobility in variant cell linesR E Williams, P S Linsley, H G Rittenhouse, et al.
Experimental Lung Research|February 24, 2001
Detection of genetic alterations in mouse lung adenocarcinomas by two-dimensional gel electrophoresisJ Liu, P Gu, G Bergman, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1993
Development of chemopreventive agents for lung and upper aerodigestive tract cancersG J Kelloff, C W Boone, V K Steele, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
DNA quantification in cervical intraepithelial neoplasia thick tissue sections by confocal laser scanning microscopyK A Crist, K Kim, P J Goldblatt, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1992
When is intervention warranted?R D Williams, D G Bostwick, C W Boone, et al.
Clinical Chemistry|February 25, 1998
Development of new cancer chemoprevention agents: role of pharmacokinetic/pharmacodynamic and intermediate endpoint biomarker monitoringR Lieberman, J A Crowell, E T Hawk, et al.
International Journal of Cancer|September 15, 1986
Cytomorphologic evaluation of the neoplastic potential of 28 cell culture lines by a panel of diagnostic cytopathologistsC W Boone, K K Sanford, J K Frost, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Surrogate endpoint biomarkers for phase II cancer chemoprevention trialsG J Kelloff, C W Boone, J A Crowell, et al.
Cancer Research|April 1, 1994
Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trialsG J Kelloff, C W Boone, V E Steele, et al.
Pageof 17

Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|April 1, 1994
Chronic toxicity studies of the potential cancer preventive 2-(difluoromethyl)-dl-ornithineJ A Crowell, E I Goldenthal, G J Kelloff, et al.
Journal of Supramolecular Structure|January 1, 1978
Independence of normal phenotypic properties and cell surface receptor mobility in variant cell linesR E Williams, P S Linsley, H G Rittenhouse, et al.
Experimental Lung Research|February 24, 2001
Detection of genetic alterations in mouse lung adenocarcinomas by two-dimensional gel electrophoresisJ Liu, P Gu, G Bergman, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1993
Development of chemopreventive agents for lung and upper aerodigestive tract cancersG J Kelloff, C W Boone, V K Steele, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
DNA quantification in cervical intraepithelial neoplasia thick tissue sections by confocal laser scanning microscopyK A Crist, K Kim, P J Goldblatt, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1992
When is intervention warranted?R D Williams, D G Bostwick, C W Boone, et al.
Clinical Chemistry|February 25, 1998
Development of new cancer chemoprevention agents: role of pharmacokinetic/pharmacodynamic and intermediate endpoint biomarker monitoringR Lieberman, J A Crowell, E T Hawk, et al.
International Journal of Cancer|September 15, 1986
Cytomorphologic evaluation of the neoplastic potential of 28 cell culture lines by a panel of diagnostic cytopathologistsC W Boone, K K Sanford, J K Frost, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Surrogate endpoint biomarkers for phase II cancer chemoprevention trialsG J Kelloff, C W Boone, J A Crowell, et al.
Cancer Research|April 1, 1994
Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trialsG J Kelloff, C W Boone, V E Steele, et al.
Pageof 17